dc.contributor.author | Ferhanoğlu, Burhan | |
dc.contributor.author | Beköz, Hüseyin Saffet | |
dc.contributor.author | Karadurmuş, Nuri | |
dc.contributor.author | Paydaş, Semra | |
dc.contributor.author | Gülbaş, Zafer | |
dc.contributor.author | Türker, Alev | |
dc.contributor.author | Toptaş, Tayfur | |
dc.contributor.author | Fıratlı Tuğlular, Tülin | |
dc.contributor.author | Tekgündüz, Emre | |
dc.contributor.author | Kaya, Ali Hakan | |
dc.contributor.author | Taştemir, N. | |
dc.contributor.author | Arat, Mutlu | |
dc.contributor.author | Pepedil Tanrıkulu, Funda | |
dc.contributor.author | Özkocaman, Vildan | |
dc.contributor.author | Abalı, Hüseyin | |
dc.contributor.author | Turgut, Mehmet | |
dc.contributor.author | Kaynar, Leylagül | |
dc.contributor.author | Karadoğan, İhsan | |
dc.contributor.author | Özbalak, Murat | |
dc.contributor.author | Özcan, Muhit | |
dc.contributor.author | Doğu, Mehmet Hilmi | |
dc.contributor.author | Kabukçu Hacıoğlu, Sibel | |
dc.contributor.author | Yıldırım, Rahsan | |
dc.contributor.author | Barışta, İbrahim | |
dc.contributor.author | Demirkaya, Metin | |
dc.contributor.author | Köseoğlu, Fatoş Dilan | |
dc.contributor.author | Yüksel, Meltem Kurt | |
dc.contributor.author | Sönmez, Mehmet | |
dc.contributor.author | Toprak, Selami Koçak | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T19:56:09Z | |
dc.date.available | 10.07.201910:49:13 | |
dc.date.available | 2019-07-10T19:56:09Z | |
dc.date.issued | 2017 | en_US |
dc.identifier.citation | Ferhanoğlu, B., Beköz, H. S., Karadurmuş, N., Paydaş, S., Gülbaş, Z., Türker, A. ... Toprak, S. K. (2017). Nivolumab for relapsed or refractory hodgkin lymphoma experience in Turkey. 22nd Congress of the European-Hematology-Association içinde (84-85. ss.). Madrid, Spain, June 22-25, 2017. | en_US |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/2595 | |
dc.description | 22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAIN | en_US |
dc.description | WOS: 000404127001176 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | The European Hematology Association | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Ferrata Storti Foundation | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hodgkin Lymphoma | en_US |
dc.subject | Turkey | en_US |
dc.subject | Experience | en_US |
dc.title | Nivolumab for relapsed or refractory hodgkin lymphoma experience in Turkey | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | 22nd Congress of the European-Hematology-Association | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0003-1237-8281 | en_US |
dc.identifier.volume | 102 | en_US |
dc.identifier.issue | Supplement: 2 | en_US |
dc.identifier.startpage | 84 | en_US |
dc.identifier.endpage | 85 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q1 | en_US |